# ğŸ§¬ AI Model for Predicting Drug Effects Using Single-Cell Transcriptomic Data
ëŒ€ê·œëª¨ ì„¸í¬â€“ì•½ë¬¼ Perturbation ë°ì´í„°(Tahoe-100M)ë¥¼ ê¸°ë°˜ìœ¼ë¡œ ì•½ë¬¼ ì²˜ë¦¬ë¡œ ìœ ë„ë˜ëŠ” ìœ ì „ì ë°œí˜„ ë³€í™”(Î”Expression)ë¥¼ í•™ìŠµí•˜ê³ ,
  
- **Forward task**: ì•½ë¬¼ + ì„¸í¬ì£¼ â†’ ìœ ì „ì ë°œí˜„ ë³€í™” ì˜ˆì¸¡  
- **Inverse task**: ì›í•˜ëŠ” ë°œí˜„ ë³€í™”ë¥¼ ê°€ì¥ ì˜ ì¬í˜„í•˜ëŠ” ì•½ë¬¼ **Ranking / Retrieval**
  
ì„ ë™ì‹œì— ë‹¤ë£¨ëŠ” Transformer ê¸°ë°˜ ë”¥ëŸ¬ë‹ ì—°êµ¬ í”„ë¡œì íŠ¸ì…ë‹ˆë‹¤.
<br/>
<br/>

## âœ¨ Key Contributions

- **Cell-aware Drug Retrieval**: ë™ì¼ ì•½ë¬¼ì´ë¼ë„ ì„¸í¬ì£¼ì— ë”°ë¼ ë°˜ì‘ì´ ë‹¬ë¼ì§„ë‹¤ëŠ” ì ì„ ëª…ì‹œì ìœ¼ë¡œ ëª¨ë¸ë§
<br/>

- **Dual Perspective Evaluation**: íšŒê·€(Î”Expression ì˜ˆì¸¡) + ë­í‚¹(Retrieval) ì§€í‘œë¥¼ ë™ì‹œì— í‰ê°€
<br/>

- **Scalable Design**: Parquet ê¸°ë°˜ ëŒ€ìš©ëŸ‰ perturbation ë°ì´í„° ì§ì ‘ ë¡œë”© ë° í•™ìŠµ
<br/>

- **Representation Alignment**: ìœ ì „ì ë°œí˜„ ë³€í™” ê³µê°„ê³¼ ì•½ë¬¼ SMILES í‘œí˜„ ê³µê°„ì˜ ì •ë ¬ ì‹¤í—˜
<br/>
<br/>

## ğŸ“ Repository Structure
ë³¸ ë ˆí¬ì§€í„°ë¦¬ì˜ êµ¬ì¡°ëŠ” ë‹¤ìŒê³¼ ê°™ìŠµë‹ˆë‹¤.
  
```
drug_ranking-main/
â”œâ”€â”€ f_p/
â”‚   â””â”€â”€ f_p_smalltargets.ipynb
â”œâ”€â”€ f_r/
â”‚   â””â”€â”€ f_r_onalldata_withcellline.ipynb
â””â”€â”€ making_data/
    â”œâ”€â”€ analysis1.ipynb
    â”œâ”€â”€ tahoe_counts_per_cell_line.csv
    â”œâ”€â”€ tahoe_counts_per_drug.csv
    â””â”€â”€ tahoe_counts_per_drug_cell_line.csv
```
<br/>
<br/>

## ğŸ§ª Dataset & Preprocessing

### Data Source
- **Tahoe-100M** ì•½ë¬¼ ë°˜ì‘ (Perturbation) ë°ì´í„°ì…‹ (Parquet í˜•ì‹)
- ê° ìƒ˜í”Œì€ `(drug, cell line, gene)`ì— ëŒ€í•œ ë°˜ì‘ ì¸¡ì •ê°’ì— í•´ë‹¹í•©ë‹ˆë‹¤.
<br/>

### Baseline Normalization
- ëª¨ë“  ë°œí˜„ê°’ì€ Î”Expression (ë°œí˜„ ë³€í™”ëŸ‰)ìœ¼ë¡œ ë³€í™˜ë˜ì—ˆìŠµë‹ˆë‹¤.
- ê¸°ì¤€ì´ ë˜ëŠ” ë² ì´ìŠ¤ë¼ì¸ì€ ê° ì„¸í¬ì£¼ë³„ **DMSO-treated control**ìœ¼ë¡œ ì •ì˜í•©ë‹ˆë‹¤.
<br/>

### Imbalance Analysis (`making_data/analysis1.ipynb`)
ë¶ˆê· í˜•í•œ ë°ì´í„°ì…‹ì„ ë‹¤ìŒ ì„¸ ê°€ì§€ ìˆ˜ì¤€ì—ì„œ êµ¬ì²´ì ìœ¼ë¡œ ë¶„ì„í–ˆìŠµë‹ˆë‹¤.
  
- ì•½ë¬¼ ìˆ˜ì¤€ (Drug-level)
- ì„¸í¬ì£¼ ìˆ˜ì¤€ (Cell-line-level)
- ì•½ë¬¼, ì„¸í¬ì£¼ ìŒ ìˆ˜ì¤€ (Drug, Cell-line pair-level)
  
ë¶„ì„ ê²°ê³¼ Long-tail ë¶„í¬ê°€ ê´€ì°°ë˜ì—ˆìœ¼ë©°, ì´ë¥¼ ê¸°ë°˜ìœ¼ë¡œ ë‹¤ìŒê³¼ ê°™ì´ ì ìš©í–ˆìŠµë‹ˆë‹¤.
- ìµœì†Œ ìƒ˜í”Œ ìˆ˜ ì„ê³„ê°’ ì„¤ì • (Thresholding)
- ì•ˆì •ì ì¸ í•™ìŠµì„ ìœ„í•œ ìŒ (Pair) ë‹¨ìœ„ í•„í„°ë§
<br/>
<br/>

## ğŸ§  Methods

### Problem Formulation

ë‹¤ìŒê³¼ ê°™ì´ ì •ì˜í•©ë‹ˆë‹¤.
  
- \( d \): ì•½ë¬¼ (Drug)
- \( c \): ì„¸í¬ì£¼ (Cell Line)
- \( x \in \mathbb{R}^G \): ê´€ì¸¡ëœ ìœ ì „ì ë°œí˜„ ë³€í™”ëŸ‰ (Gene Expression Change0
  
ìš°ë¦¬ì˜ ëª©í‘œëŠ” ë‹¤ìŒ ì¡°ê±´ì„ ë§Œì¡±í•˜ëŠ” ëª¨ë¸ ( f(d, c) \rightarrow \hat{x} )ë¥¼ í•™ìŠµí•˜ëŠ” ê²ƒì…ë‹ˆë‹¤.
  
- \( \hat{x} \approx x \): ìˆœë°©í–¥ ì˜ˆì¸¡ (Forward Prediction)
- ( \hat{x} )ì™€ ì¿¼ë¦¬ ì‹œê·¸ë‹ˆì²˜(Query Signature) ê°„ì˜ ìœ ì‚¬ë„ë¥¼ ê¸°ë°˜ìœ¼ë¡œ ì•½ë¬¼ì˜ ìˆœìœ„(Rank)ë¥¼ ë§¤ê¸¸ ìˆ˜ ìˆì–´ì•¼ í•©ë‹ˆë‹¤.
<br/>

### Model Architecture (f_r)

**Input Sequence**
```
[CLS] [DRUG] [CELL] gâ‚ gâ‚‚ ... gâ‚™
```

- `gáµ¢`: gene token embedding + projected Î”Expression value
- `[DRUG]`: SMILES-based drug embedding
- `[CELL]`: pretrained cell line embedding

**Encoder**
- Transformer encoder (Cell2Sentence-style)
- Positional embeddings applied

**Output**
- `CLS` token â†’ MLP head â†’ predicted Î”Expression vector

---

### Fast Prototyping Model (f_p)

- Focused on **small target gene sets**
- Trained with:
  - Target gene matching loss
  - CLIP-like contrastive loss between:
    - Drug-induced expression representation
    - SMILES embedding

This stage is used for:
- Architecture sanity check
- Retrieval metric validation

---

### Loss Functions

#### Forward Regression Loss
- Mean Squared Error (MSE)

#### Ranking / Alignment Loss
- Cosine similarity based loss
- Contrastive / ranking loss (InfoNCE-style)

#### Total Loss (example)
```
L = Î»_mse Â· L_mse + Î»_rank Â· L_rank + Î»_align Â· L_align
```

Warm-up strategy is used where ranking loss weight is gradually increased.
<br/>
<br/>

## ğŸ§ª Experiments

### Experimental Setup

- **Train / Validation / Test split**
  - Per (drug, cell line) pair
- **Evaluation**
  - Global metrics
  - Per-cell-line stratified metrics
  - Per-drug stratified metrics

### Tasks

#### 1) Forward Prediction
- Predict Î”Expression given (drug, cell)

#### 2) Inverse Retrieval
- Given a query Î”Expression signature:
  - Rank candidate drugs by similarity

---

### Metrics

#### Regression
- MSE
- MAE
- Cosine similarity
- Pearson correlation
- Spearman correlation

#### Ranking / Retrieval
- Precision@K
- Recall@K
- NDCG@K
- mAP@K

---

### Key Observations

- Incorporating **cell line tokens** significantly improves ranking stability
- Warm-up before applying ranking loss improves convergence
- Learned gene embeddings form structured manifolds even without pathway supervision

---

## â–¶ï¸ How to Run
1. Analyze data imbalance
```
making_data/analysis1.ipynb
```
<br/>

2. Fast prototyping
```
f_p/f_p_smalltargets.ipynb
```
<br/>

3. Full retrieval & ranking
```
f_r/f_r_onalldata_withcellline.ipynb
```
<br/>
<br/>

## ğŸ›  Requirements
```
pip install torch numpy pandas pyarrow scanpy scipy scikit-learn matplotlib tqdm
```
<br/>
<br/>

## ğŸ§© Notes
- (ì•½ë¬¼, ì„¸í¬ì£¼) ë°ì´í„°ì˜ ë¶ˆê· í˜•ì´ ì‹¬ê°í•˜ì—¬ í•„í„°ë§ ê³¼ì •ì´ í•„ìˆ˜ì ì…ë‹ˆë‹¤.
- SMILES ì„ë² ë”©ì€ ì•½ë¬¼ ë©”íƒ€ë°ì´í„°ì˜ ì •ë ¬ ìˆœì„œì™€ ë°˜ë“œì‹œ ì¼ì¹˜ (Align)í•´ì•¼ í•©ë‹ˆë‹¤.
<br/>
<br/>
